Drug Profile
Somatropin - Merck Serono
Alternative Names: r-hGH; Saizen; Serostim; SJ 0011; ZorbtiveLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Merck Serono
- Developer Bioject; Merck Serono; Savient Pharmaceuticals
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Cachexia; Growth disorders; Short bowel syndrome; Short stature; Somatotropin deficiency
- Discontinued Female infertility; Lipodystrophy
Most Recent Events
- 09 Apr 2021 Discontinued - Phase-II for Female infertility (Adjunctive treatment) in Canada (SC)
- 09 Apr 2021 Discontinued - Phase-III for Female infertility (Adjunctive treatment) in Australia (SC)
- 09 Apr 2021 Discontinued - Phase-III for Female infertility (Adjunctive treatment) in New Zealand (SC)